GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
39.27
-0.33 (-0.83%)
At close: Apr 18, 2024, 4:00 PM
39.18
-0.09 (-0.23%)
After-hours: Apr 18, 2024, 7:57 PM EDT
GSK Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GSK stock have an average target of 46, with a low estimate of 44 and a high estimate of 48. The average target predicts an increase of 17.14% from the current stock price of 39.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 23, 2024.
Analyst Ratings
The average analyst rating for GSK stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $44 | Hold | Initiates | $44 | +12.04% | Jan 23, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $39 → $48 | Hold → Strong Buy | Upgrades | $39 → $48 | +22.23% | Jan 3, 2024 |
| DZ Bank | DZ Bank | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2022 |
| Barclays | Barclays | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 5, 2021 |
Financial Forecast
Revenue This Year
32.52B
from 30.33B
Increased by 7.24%
Revenue Next Year
34.49B
from 32.52B
Increased by 6.03%
EPS This Year
1.63
from 2.40
Decreased by -32.20%
EPS Next Year
1.82
from 1.63
Increased by 11.90%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.0B | 36.7B | 38.3B | 45.6B | 47.1B |
| Avg | 32.5B | 34.5B | 36.1B | 37.5B | 37.7B |
| Low | 30.3B | 31.6B | 32.5B | 33.1B | 31.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.3% | 13.0% | 11.1% | 26.2% | 25.8% |
| Avg | 7.2% | 6.0% | 4.7% | 3.8% | 0.6% |
| Low | -0.1% | -3.0% | -5.8% | -8.3% | -16.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.70 | 1.95 | 2.19 | 2.83 | 2.11 |
| Avg | 1.63 | 1.82 | 1.97 | 2.10 | 1.88 |
| Low | 1.51 | 1.53 | 1.54 | 1.67 | 1.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -29.1% | 20.2% | 20.6% | 43.6% | 0.5% |
| Avg | -32.2% | 11.9% | 8.5% | 6.2% | -10.3% |
| Low | -37.0% | -6.0% | -15.3% | -15.3% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.